HAUS5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.855400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.450400E-01
Normal-vs-Stage2
4.929200E-01
Normal-vs-Stage3
3.286400E-01
Normal-vs-Stage4
4.378600E-01
Stage1-vs-Stage2
6.548600E-01
Stage1-vs-Stage3
2.382800E-01
Stage1-vs-Stage4
9.574800E-01
Stage2-vs-Stage3
1.622210E-01
Stage2-vs-Stage4
6.841000E-01
Stage3-vs-Stage4
2.381800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.898800E-01
Normal-vs-AfricanAmerican
2.683800E-01
Normal-vs-Asian
5.453400E-01
Caucasian-vs-AfricanAmerican
5.907200E-01
Caucasian-vs-Asian
6.103400E-01
AfricanAmerican-vs-Asian
5.230400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.735000E-01
Normal-vs-Female
5.029000E-01
Male-vs-Female
5.038600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.851400E-01
Normal-vs-Age(41-60Yrs)
5.034800E-01
Normal-vs-Age(61-80Yrs)
4.799400E-01
Normal-vs-Age(81-100Yrs)
4.657200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.731200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.743800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.974800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.412400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.404600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.767800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.553600E-01
Normal-vs-Daily Drinker
5.523800E-01
Normal-vs-Weekly Drinker
3.888000E-01
Normal-vs-Occasional Drinker
6.016800E-01
Normal-vs-Social Drinker
4.472000E-01
Non Drinker-vs-Daily Drinker
2.413800E-01
Non Drinker-vs-Weekly Drinker
1.409810E-01
Non Drinker-vs-Occasional Drinker
1.466960E-01
Non Drinker-vs-Social Drinker
9.124200E-01
Daily Drinker-vs-Weekly Drinker
5.572200E-01
Daily Drinker-vs-Occasional Drinker
6.643800E-01
Daily Drinker-vs-Social Drinker
1.918210E-01
Weekly Drinker-vs-Occasional Drinker
8.537600E-01
Weekly Drinker-vs-Social Drinker
1.489600E-01
Occasional Drinker-vs-Social Drinker
1.111960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.900000E-01
Normal-vs-Grade 2
8.306400E-01
Normal-vs-Grade 3
8.493600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.859000E-01
Grade 1-vs-Grade 3
2.530400E-01
Grade 1-vs-Grade 4
7.900000E-01
Grade 2-vs-Grade 3
5.709800E-01
Grade 2-vs-Grade 4
8.306400E-01
Grade 3-vs-Grade 4
8.493600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.106800E-01
Normal-vs-NonDiabetic
5.004000E-01
Diabetic-vs-NonDiabetic
8.729600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.689400E-01
Normal-vs-NoPancreatitis
4.830800E-01
Pancreatitis-vs-NoPancreatitis
1.658780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.896200E-01
Normal-vs-N1
4.779600E-01
N0-vs-N1
8.161200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.083800E-01
Normal-vs-TP53-NonMutant
4.699800E-01
TP53-Mutant-vs-TP53-NonMutant
4.306400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
